From dry eye to GLP-1s, this year's conference brought a variety of insights from key experts in optometry. Want more ...
Gromacki said that, at the time of the discussion, there were no FDA-approved drug-eluting lenses in the US. She mentioned ...
Susan Gromacki, OD, MS, FAAO, FSLS, details one of her AAOpt 2026 sessions, titled "Advances in Contact Lens Care for the New Contact Lens Technologies." Kevin Chan, OD, MS, discusses an AAOpt 2026 ...
The approval gives eye care providers a new pharmacologic option for adults with presbyopia. Phentolamine is a non-selective alpha-1 and alpha-2 adrenergic antagonist, and the drug reduces pupil ...
Walline, American Academy of Optometry president, shares this year's conference attendance numbers, clinical pearls, and what ...
Thomas Wong, OD, FAAO, details a session he presented alongside Ronald Gentile, MD, FACS, FASRS, at AAOpt 2026. Thomas Wong, ...
IDOC's 2025 benchmarks from 175-plus independent OD practices put median practice net at 31% of revenue as variable costs ...
Patient quality of life has been shown to be severely impaired by the associated ocular surface symptoms, so treatment aims for symptomatic relief and prevention of further damage to the ocular ...
A single Epioxa epi-on cross-linking treatment sustained a 1.9 D Kmax improvement through three years in keratoconus, with no ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results